X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7835) 7835
Publication (794) 794
Patent (256) 256
Book Review (116) 116
Book Chapter (60) 60
Book / eBook (25) 25
Conference Proceeding (23) 23
Magazine Article (23) 23
Newsletter (18) 18
Dissertation (6) 6
Trade Publication Article (3) 3
Government Document (2) 2
Newspaper Article (2) 2
Web Resource (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6177) 6177
index medicus (3116) 3116
female (2900) 2900
combined modality therapy (2690) 2690
male (2462) 2462
animals (2084) 2084
immunology (1934) 1934
oncology (1541) 1541
immunotherapy (1524) 1524
vaccines (1472) 1472
vaccination (1448) 1448
infant (1263) 1263
mice (1234) 1234
cancer (1181) 1181
middle aged (1157) 1157
adult (1152) 1152
antineoplastic combined chemotherapy protocols - therapeutic use (1043) 1043
immunization (1024) 1024
vaccines, combined - immunology (991) 991
medicine, research & experimental (948) 948
treatment outcome (937) 937
child (885) 885
aged (882) 882
vaccines, combined - administration & dosage (879) 879
chemotherapy (830) 830
care and treatment (749) 749
child, preschool (739) 739
health aspects (668) 668
cancer vaccines - therapeutic use (660) 660
vaccines, combined - adverse effects (653) 653
research (650) 650
infectious diseases (642) 642
immunogenicity (619) 619
adolescent (605) 605
children (605) 605
immunization schedule (583) 583
combined vaccines (581) 581
antigens (563) 563
pediatrics (548) 548
dendritic cells (545) 545
antineoplastic agents - therapeutic use (539) 539
vaccine (514) 514
clinical trials as topic (513) 513
immunotherapy - methods (498) 498
vaccines, combined (493) 493
tumors (491) 491
safety (466) 466
severe combined immunodeficiency (444) 444
prognosis (441) 441
cancer vaccines - immunology (438) 438
immune response (430) 430
bcg vaccine - therapeutic use (422) 422
lymphocytes (417) 417
analysis (402) 402
neoplasm staging (401) 401
article (398) 398
immunity (395) 395
antibodies (386) 386
therapy (381) 381
infants (379) 379
melanoma (376) 376
veterinary sciences (375) 375
infection (370) 370
measles-mumps-rubella vaccine (367) 367
medicine (366) 366
neoplasms - therapy (363) 363
time factors (363) 363
clinical trials (362) 362
follow-up studies (359) 359
tetanus (357) 357
biotechnology & applied microbiology (351) 351
mice, inbred balb c (351) 351
risk factors (342) 342
cell line, tumor (341) 341
infections (338) 338
mice, inbred c57bl (338) 338
proteins (337) 337
diphtheria (333) 333
pharmacology & pharmacy (332) 332
t cells (328) 328
viruses (328) 328
antibodies, viral - blood (324) 324
research article (322) 322
hepatitis b vaccines - administration & dosage (316) 316
medicine, general & internal (312) 312
allergy and immunology (310) 310
neoplasms - immunology (307) 307
immune system (305) 305
medical research (302) 302
diphtheria-tetanus-pertussis vaccine - administration & dosage (301) 301
t-lymphocytes - immunology (301) 301
cancer vaccines (298) 298
hepatitis b vaccines - immunology (298) 298
drug therapy (296) 296
urinary bladder neoplasms - therapy (294) 294
age (293) 293
expression (291) 291
antibodies, bacterial - blood (289) 289
lymphocytes t (288) 288
infant, newborn (286) 286
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (15) 15
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Robarts - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7444) 7444
French (152) 152
Russian (152) 152
German (144) 144
Chinese (133) 133
Spanish (90) 90
Japanese (77) 77
Italian (43) 43
Polish (27) 27
Dutch (14) 14
Portuguese (14) 14
Korean (11) 11
Hungarian (10) 10
Czech (8) 8
Danish (8) 8
Romanian (8) 8
Bulgarian (5) 5
Swedish (4) 4
Norwegian (3) 3
Croatian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 20, pp. 2379 - 2386
Highlights • ProQuad® and hexavalent vaccine immunogenicity is similar if given together or alone. • ProQuad® and hexavalent vaccine have consistent safety... 
Allergy and Immunology | ProQuad® immunization | Rubella | Measles | ClinicalTrials.gov NCT: 00432042 | Varicella | Mumps | Hexavalent vaccine | ProQuad ® immunization | MEDICINE, RESEARCH & EXPERIMENTAL | PEDIATRIC COMBINATION VACCINES | IMMUNIZATION PRACTICES ACIP | MMRV VACCINATION | PREVENTION | RISK | FEBRILE SEIZURES | IMMUNOLOGY | ProQuad (R) immunization | CHILDREN | ADVISORY-COMMITTEE | IMPACT | RECOMMENDATIONS | Immunization, Secondary - adverse effects | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Vaccination | Infant | Male | Haemophilus Vaccines - administration & dosage | Haemophilus influenzae type b - immunology | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Antibodies, Viral - blood | Poliovirus Vaccine, Inactivated - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Female | Immunization Schedule | Antibodies, Bacterial - blood | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Chickenpox Vaccine - adverse effects | Hepatitis B Vaccines - administration & dosage | Measles-Mumps-Rubella Vaccine - administration & dosage | Chickenpox Vaccine - administration & dosage | Haemophilus Vaccines - immunology | Measles-Mumps-Rubella Vaccine - adverse effects | Measles-Mumps-Rubella Vaccine - immunology | Vaccines, Combined - adverse effects | Hepatitis B Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - adverse effects | Antibodies, Bacterial - immunology | Antibodies, Viral - immunology | Hepatitis B Vaccines - immunology | Chickenpox Vaccine - immunology | Infants | Safety and security measures | Vaccines | Schedules | Immunization | Chicken pox | Infections | Diphtheria | Whooping cough | Hepatitis | Poliomyelitis | Influenza | Response rates | Tetanus
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 11/2018, Volume 18, Issue 11, pp. 1260 - 1268
The immunogenicity of acellular pertussis vaccines and persistence of immunity after vaccination might be improved by using genetically inactivated pertussis... 
IMMUNIZATION | IMMUNITY | INFECTIOUS DISEASES | PROTECTION | DIPHTHERIA | TETANUS | TDAP | CHILDREN | DTAP | Single-Blind Method | Antitoxins - blood | Humans | Pertussis Vaccine - administration & dosage | Vaccines, Acellular - immunology | Male | Vaccines, Synthetic - immunology | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Drug-Related Side Effects and Adverse Reactions - pathology | Time Factors | Vaccines, Synthetic - adverse effects | Vaccines, Combined - genetics | Female | Pertussis Vaccine - immunology | Antibodies, Bacterial - blood | Vaccines, Synthetic - genetics | Pertussis Vaccine - genetics | Vaccines, Acellular - administration & dosage | Pertussis Vaccine - adverse effects | Pertussis Toxin - immunology | Seroconversion | Drug-Related Side Effects and Adverse Reactions - epidemiology | Pertussis Toxin - genetics | Vaccines, Acellular - adverse effects | Vaccines, Acellular - genetics | Vaccines, Combined - adverse effects | Asia | Adolescent | Vaccines, Synthetic - administration & dosage | Pertussis vaccines | Medical research | Biological products | Vaccination | Clinical trials | Medicine, Experimental | Antigenic determinants | Neonates | Adolescence | Immunoglobulin G | Antibodies | Licenses | Vaccines | Immunity | Pertussis toxin | Pertussis | Randomization | Combined vaccines | Teenagers | Safety | Adolescents | Drug dosages | Recombinant | Toxoids | Immunoglobulins | Preservation | Complications | Epitopes | Diphtheria | Whooping cough | Pregnancy | Studies | Organic chemistry | Immunogenicity | Tetanus
Journal Article
Vaccine, ISSN 0264-410X, 2010, Volume 28, Issue 32, pp. 5272 - 5279
Journal Article
Vaccine, ISSN 0264-410X, 02/2018, Volume 36, Issue 7, pp. 986 - 996
BACKGROUND: Infants with history of prematurity (<37 weeks gestation) and low birth weight (LBW, <2500 g) are at high risk of infection due to functional... 
Premature | DTPa-HBV-IPV/Hib | Hexavalent vaccine | Primary vaccination | Preterm | SYSTEMATIC ANALYSIS | MEDICINE, RESEARCH & EXPERIMENTAL | APNEA | RISK-FACTORS | SEROGROUP-C | PREMATURE-INFANTS | PERSISTENCE | CARDIORESPIRATORY EVENTS | IMMUNOLOGY | HOSPITALIZATION | BOOSTER VACCINATION | REACTOGENICITY | Immunogenicity, Vaccine | Outcome Assessment (Health Care) | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Vaccination | Infant | Haemophilus Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Poliovirus Vaccine, Inactivated - immunology | Vaccines, Conjugate - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Public Health Surveillance | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Product Surveillance, Postmarketing | Infant, Newborn | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Global Health | Hepatitis B Vaccines - administration & dosage | Mortality | Haemophilus Vaccines - immunology | Morbidity | Vaccines, Conjugate - administration & dosage | Vaccines, Combined - adverse effects | Hepatitis B Vaccines - adverse effects | Infant, Premature | Poliovirus Vaccine, Inactivated - adverse effects | Hepatitis B Vaccines - immunology | Immunity, Cellular | Antigens | Whooping-cough | Safety and security measures | Hemophilus infections | Infants (Premature) | Vaccines | Diphtheria | Hepatitis B
Journal Article
Vaccine, ISSN 0264-410X, 2016, Volume 35, Issue 3, pp. 452 - 458
Highlights • DTaP-IPV-HB-PRP-T immunogenicity is similar when given concomitantly with a meningococcal C conjugate vaccine or alone. • The safety profile of... 
Allergy and Immunology | Co-administration | Meningococcal C | Safety | Immunogenicity | Vaccination | Hexavalent | MEDICINE, RESEARCH & EXPERIMENTAL | DIFFERENCE | COMBINATION VACCINES | B VACCINE | IMMUNOLOGY | TETANUS TOXOID CONJUGATE | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Infant | Haemophilus Vaccines - administration & dosage | Pneumococcal Vaccines - administration & dosage | Healthy Volunteers | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Meningococcal Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - immunology | Hepatitis B Antibodies - blood | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Immunization Schedule | Antibodies, Bacterial - blood | Rotavirus Vaccines - administration & dosage | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Hepatitis B Vaccines - administration & dosage | Haemophilus Vaccines - immunology | Vaccines, Combined - adverse effects | Hepatitis B Vaccines - adverse effects | Finland | Poliovirus Vaccine, Inactivated - adverse effects | Hepatitis B Vaccines - immunology | Meningococcal Vaccines - immunology | Meningococcal Vaccines - administration & dosage | Usage | Infants | Vaccines | Antigens | Hepatitis | Immunization | Pain | Poliomyelitis | Viruses | Tetanus | Diphtheria | Age | Whooping cough
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 07/2016, Volume 35, Issue 7, pp. e206 - e219
BACKGROUND:Immune responses and safety profiles may be affected when vaccines are coadministered. We evaluated the immunogenicity, safety and reactogenicity of... 
IMMUNE-RESPONSE | INFECTIOUS DISEASES | BACTERIA | booster vaccination | DTPa-IPV-Hib coadministration | HAEMOPHILUS-INFLUENZAE | IMMUNOLOGY | CHILDHOOD VACCINES | immunogenicity | NASOPHARYNGEAL CARRIAGE | 10-valent pneumococcal conjugate vaccine | PROPHYLACTIC PARACETAMOL | STREPTOCOCCUS-PNEUMONIAE | reactogenicity | DISEASE | PEDIATRICS | NETHERLANDS | PHID-CV | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Vaccines, Conjugate - adverse effects | Child, Preschool | Infant | Male | Haemophilus Vaccines - administration & dosage | Pneumococcal Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Poliovirus Vaccine, Inactivated - immunology | Immunoglobulin D - immunology | Vaccines, Conjugate - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Pneumococcal Infections - immunology | Immunization, Secondary | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Female | Pneumococcal Vaccines - adverse effects | Antibodies, Bacterial - blood | Diphtheria-Tetanus-Pertussis Vaccine - adverse effects | Hepatitis B Vaccines - administration & dosage | Haemophilus Vaccines - immunology | Vaccines, Conjugate - administration & dosage | Vaccines, Combined - adverse effects | Hepatitis B Vaccines - adverse effects | Pneumococcal Infections - prevention & control | Pneumococcal Vaccines - immunology | Poliovirus Vaccine, Inactivated - adverse effects | Antibodies, Viral - immunology | Hepatitis B Vaccines - immunology
Journal Article
Vaccine, ISSN 0264-410X, 2011, Volume 29, Issue 25, pp. 4264 - 4273
Abstract Tetravalent meningococcal serogroups ACWY conjugate vaccines will provide an advantage to those at most risk of invasive meningococcal disease; namely... 
Allergy and Immunology | Tetravalent meningococcal vaccine | Hexavalent vaccine | Conjugate vaccine | DTaP-HBV-IPV/Hib combination vaccine | Bactericidal activity | MEDICINE, RESEARCH & EXPERIMENTAL | NEISSERIA-MENINGITIDIS | PREVENTION | IMMUNOSORBENT-ASSAY ELISA | SERUM ANTIBODIES | IMMUNOLOGY | PROTECTIVE LEVEL | TODDLERS | CAPSULAR POLYSACCHARIDE | IMPACT | INFLUENZAE TYPE-B | DISEASE | Haemophilus Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Vaccines, Conjugate - adverse effects | Infant | Male | Haemophilus Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Antibodies, Viral - blood | Meningococcal Vaccines - adverse effects | Poliovirus Vaccine, Inactivated - immunology | Vaccines, Conjugate - immunology | Female | Diphtheria-Tetanus-acellular Pertussis Vaccines - adverse effects | Antibodies, Bacterial - blood | Diphtheria-Tetanus-acellular Pertussis Vaccines - immunology | Tetanus Toxoid - adverse effects | Haemophilus Vaccines - immunology | Tetanus Toxoid - administration & dosage | Vaccines, Conjugate - administration & dosage | Vaccines, Combined - adverse effects | Poliovirus Vaccine, Inactivated - adverse effects | Diphtheria-Tetanus-acellular Pertussis Vaccines - administration & dosage | Meningococcal Vaccines - immunology | Meningococcal Vaccines - administration & dosage | Tetanus Toxoid - immunology
Journal Article
The Pediatric Infectious Disease Journal, ISSN 0891-3668, 04/2009, Volume 28, Issue 4 Suppl, pp. S97 - S108
BACKGROUND:The choice of non-typeable Haemophilus influenzae Protein D as main carrier protein in the candidate 10-valent pneumococcal conjugate vaccine... 
Pneumococcal conjugate vaccine | DTPw-combined | Booster vaccination | Primary vaccination | DTPa-combined | Meningococcal conjugate vaccine | Streptococcus pneumoniae | HIB | INFECTIOUS DISEASES | LINKED-IMMUNOSORBENT-ASSAY | booster vaccination | primary vaccination | B VACCINE | SERUM ANTIBODIES | IMMUNOLOGY | PROTECTIVE LEVEL | CAPSULAR POLYSACCHARIDE | IMMUNIZATION | meningococcal conjugate vaccine | INFANTS | PEDIATRICS | NEISSERIA-MENINGITIDIS SEROGROUP | REACTOGENICITY | pneumococcal conjugate vaccine | Humans | Vaccination | Infant | Haemophilus Vaccines - administration & dosage | Pneumococcal Vaccines - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Antibodies, Viral - blood | Immunoglobulin D - immunology | Vaccines, Conjugate - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Immunization, Secondary | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Immunization Programs | Immunization Schedule | Bacterial Proteins - immunology | Antibodies, Bacterial - blood | Carrier Proteins - immunology | Hepatitis B Vaccines - administration & dosage | Heptavalent Pneumococcal Conjugate Vaccine | Treatment Outcome | Poliovirus Vaccines - administration & dosage | Haemophilus Vaccines - immunology | Randomized Controlled Trials as Topic | Vaccines, Conjugate - administration & dosage | Pneumococcal Vaccines - immunology | Hepatitis B Vaccines - immunology | Meningococcal Vaccines - immunology | Poliovirus Vaccines - immunology | Lipoproteins - immunology | Meningococcal Vaccines - administration & dosage
Journal Article
Vaccine, ISSN 0264-410X, 09/2018, Volume 36, Issue 37, pp. 5519 - 5523
A newly developed bovine-human reassortant pentavalent vaccine (BRV-PV, ROTASIIL®) was tested for its potential effect on the immunogenicity of concomitantly... 
Bovine-human reassortant pentavalent rotavirus vaccine (BRV-PV) | Immune response | Interference | DTwP-HepB-Hib vaccine | Oral polio vaccine (OPV) | MEDICINE, RESEARCH & EXPERIMENTAL | Bovine-human reassortant pentavalent | rotavirus vaccine (BRV-PV) | EFFICACY | ORAL POLIOVIRUS | IMMUNOLOGY | TRIAL | IMPACT | MONOVALENT | BIVALENT | Immunogenicity, Vaccine | Poliovirus Vaccine, Oral - immunology | Immunoglobulin G - blood | Poliovirus Vaccine, Inactivated - administration & dosage | Humans | Infant | Male | Haemophilus Vaccines - administration & dosage | Poliovirus Vaccine, Oral - administration & dosage | Vaccines, Combined - administration & dosage | Vaccines, Combined - immunology | Antibodies, Viral - blood | Poliovirus Vaccine, Inactivated - immunology | Diphtheria-Tetanus-Pertussis Vaccine - administration & dosage | Reassortant Viruses - immunology | Cattle | Diphtheria-Tetanus-Pertussis Vaccine - immunology | Vaccines, Attenuated - administration & dosage | Female | Immunization Schedule | Rotavirus Vaccines - administration & dosage | Rotavirus Vaccines - immunology | Hepatitis B Vaccines - administration & dosage | Haemophilus Vaccines - immunology | Vaccines, Attenuated - immunology | Animals | Hepatitis B Vaccines - immunology | Rotavirus Infections - prevention & control | Laboratories | Immunoglobulin G | Vaccination | Antibodies | Viruses | Infants | Vaccines | Pertussis | Confidence intervals | Hepatitis | Randomization | Poliomyelitis | Population | Hepatitis B virus | Age | Antigens | Diphtheria | Whooping cough | Immunogenicity | Lymphocytes B | Tetanus | Binding sites | Hepatitis B
Journal Article
Clinical and Vaccine Immunology, ISSN 1556-6811, 01/2010, Volume 17, Issue 1, pp. 154 - 159
Journal Article
Journal Article
Expert Review of Vaccines, ISSN 1476-0584, 06/2018, Volume 17, Issue 6, pp. 513 - 524
Journal Article
Vaccine, ISSN 0264-410X, 2015, Volume 33, Issue 12, pp. 1440 - 1445